Colorectal Cancer Treatments and Studies
Most cited papers
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine · 2008 · 13,250 citations
- Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine · 2004 · 11,040 citations
- PD-1 Blockade in Tumors with Mismatch-Repair DeficiencyNew England Journal of Medicine · 2015 · 9,526 citations
- Comprehensive molecular characterization of human colon and rectal cancerNature · 2012 · 8,668 citations
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular CarcinomaNew England Journal of Medicine · 2020 · 7,704 citations
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine · 1988 · 6,809 citations
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical OutcomeScience · 2006 · 6,671 citations
- Global patterns and trends in colorectal cancer incidence and mortalityGut · 2016 · 5,412 citations
- Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the LiteratureCase Reports in Oncology · 2015 · 5,282 citations
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology · 2012 · 5,281 citations
- Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal CancerNew England Journal of Medicine · 2004 · 5,069 citations
- Lessons from Hereditary Colorectal CancerCell · 1996 · 4,959 citations
- Modified RECIST (mRECIST) Assessment for Hepatocellular CarcinomaSeminars in Liver Disease · 2010 · 4,413 citations
- AASLD guidelines for the treatment of hepatocellular carcinomaHepatology · 2017 · 4,121 citations
- Folic Acid for the Prevention of Colorectal AdenomasJAMA · 2007 · 939 citations
- Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDHScience · 2015 · 925 citations
Metadata from OpenAlex (CC0).